• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Galectin Therapeutics Inc

+ Add to Watchlist


7.2200 USD 7.3200 50.34%

As of 10:03:20 ET on 07/29/2014.

Snapshot for Galectin Therapeutics Inc (GALT)

Open: 7.1000 Day's Range: 6.7000 - 7.7500 Volume: 1,716,568
Previous Close: 14.5400 52wk Range: 4.8000 - 19.1099 1-Yr Rtn: +51.40%

Stock Chart for GALT

No chart data available.
  • GALT:US 7.2750
  • 1D
  • 1M
  • 1Y
Interactive GALT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GALT

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.8413
Est. EPS (USD) (12/2014) -0.8400
Est. PEG Ratio -
Market Cap (M USD) 164.09
Shares Outstanding (M) 21.91
30 Day Average Volume 398,508
Price/Book (mrq) 155.6922
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GALT

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for GALT

Galectin Therapeutics Inc. is a drug development company. The Company creates new therapies for fibrotic disease and cancer using its carbohydrate technology that targets galectin proteins which are key mediators of biologic and pathologic functions. Gelectin uses naturally occurring carbohydrate polymers with galactose residues to create complex carbohydrates.

James C CzirrChairman/Co-FounderPeter G TraberPresident/CEO/Chief Medical Ofcr
Jack W CallicuttChief Financial OfficerHarold H ShlevinChief Operating Officer
More Company Profile & Key Executives for GALT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil